DekaBank Deutsche Girozentrale
PMVP icon

DekaBank Deutsche Girozentrale’s PMV Pharmaceuticals PMVP Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,600
Closed -$152K – 1353
2022
Q4 		$152K Hold
17,600
– – ﹤0.01% 1262
2022
Q3 		$212K Hold
17,600
– – ﹤0.01% 1218
2022
Q2 		$245K Hold
17,600
– – ﹤0.01% 1151
2022
Q1 		$379K Buy
17,600
+1,600
+10% +$28.2K ﹤0.01% 1108
2021
Q4 		$375K Buy
+16,000
New +$387K ﹤0.01% 1161

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale's PMVP Position: Q1 2023 in Review

DekaBank Deutsche Girozentrale sold out of PMV Pharmaceuticals (PMVP) in Q1 2023, closing a stake of 17,600 shares — an estimated $152K sold.

DekaBank Deutsche Girozentrale first reported a position in PMVP in Q4 2021 and held it in 5 quarters. The position peaked at $379K in Q1 2022. 111 funds tracked by Wall St. Rank hold PMVP as of Q1 2023.

  • DekaBank Deutsche Girozentrale reported no remaining PMV Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 17,600 PMV Pharmaceuticals shares in Q1 2023, an estimated $152K.
  • DekaBank Deutsche Girozentrale first reported a position in PMV Pharmaceuticals in Q4 2021 and held it in 5 quarters.
  • DekaBank Deutsche Girozentrale's PMV Pharmaceuticals position peaked at $379K in Q1 2022.
  • 111 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2023, filed 24 Apr 2023.